Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-04-30 | Mr. Hurwitz is a Managing Director of Precision Bioventures, LLC, a consulting and advisory firm. |
| 2015-04-09 | Mr. Hurwitz received his J.D. and M.B.A. degrees from the University of California at Berkeley in 1990 and a B.A. in molecular biology from Cornell University in 1985. |
| 2016-04-07 | Mr. Hurwitz has served as a director since October 2004. Mr. Hurwitz is a Managing Director of Precision BioVentures, LLC, a consulting and investment advisory firm. He was a Director of Alta BioPharma III, L.P., and Alta Partners VIII, funds affiliated with Alta Partners, a venture capital firm, from 2002 through December 2014. Mr. Hurwitz also serves as a director of Applied Genetic Technologies Corporation, a publicly held company. The Board believes that Mr. Hurwitz’s financial and scientific expertise, as well as his deep understanding of the biotechnology industry, makes him an important resource for the Board as it assesses both financial and strategic decisions. |
| 2017-04-04 | Mr. Hurwitz is a Managing Director of MPM Capital, a venture capital firm. From January 2015 through December 2016, Mr. Hurwitz was a Managing Director of Precision BioVentures, LLC, a consulting and investment advisory firm. He was a director of Alta BioPharma III, L.P., and Alta Partners VIII, funds affiliated with Alta Partners, a venture capital firm, from 2002 through December 2014. |
| 2018-04-06 | Mr. Hurwitz is a Managing Director of MPM Capital, a venture capital firm. From January 2015 through December 2016, Mr. Hurwitz was a Managing Director of Precision BioVentures, LLC, a consulting and investment advisory firm. He was a director of Alta BioPharma III, L.P., and Alta Partners VIII, funds affiliated with Alta Partners, a venture capital firm, from 2002 through December 2014. |
| 2019-04-05 | Mr. Hurwitz received a JD and MBA degree from the University of California at Berkeley in 1990 and a BA in molecular biology from Cornell University in 1985... The Board believes that Mr. Hurwitz’s financial and scientific expertise... makes him an important asset to our Board. |
| 2020-04-03 | Mr. Hurwitz has served as a director since October 2004. Mr. Hurwitz is a Managing Director of MPM Capital, a life sciences venture capital firm. Prior to joining MPM Capital, Mr. Hurwitz was the founding Managing Director of Precision Bioventures, LLC, a consulting and investment advisory firm. He was a director of Alta BioPharma III, L.P., and Alta Partners VIII, L.P., funds affiliated with Alta Partners, a venture capital firm, from 2002 through December 2014. Mr. Hurwitz also serves as a director of Applied Genetic Technologies Corporation, a publicly held company. Mr. Hurwitz received J.D. and M.B.A degrees from the University of California at Berkeley in 1990 and a B.A. in molecular biology from Cornell University in 1985. |
| 2021-04-02 | Mr. Hurwitz received J.D. and M.B.A degrees from the University of California at Berkeley in 1990 and a B.A. in molecular biology from Cornell University in 1985. |
| 2022-04-08 | Mr. Hurwitz received J.D. and M.B.A degrees from the University of California at Berkeley in 1990 and a B.A. in molecular biology from Cornell University in 1985. |
| 2023-04-17 | Mr. Hurwitz received J.D. and M.B.A degrees from the University of California at Berkeley in 1990 and a B.A. in molecular biology from Cornell University in 1985. |
| Filing Date | Source Excerpt |
|---|---|
| 2009-05-20 | Edward Hurwitz has served as a director of Alta Partners, a venture capital firm, since June 2002. ... Mr. Hurwitz was appointed as a director pursuant to the Investor Rights Agreement executed in connection with Alta Partners’ purchase of our securities in the Private Placement. ... The Audit Committee is chaired by Mr. Fust, and also includes Mr. Hurwitz and Dr. Stump. ... The Compensation Committee is chaired by Mr. Misfeldt, and also includes Messrs. Hurwitz and Fust. ... The following table sets forth the compensation information for our non-employee directors, ... Edward Hurwitz Fees Earned or Paid in Cash $23,000, Option Awards $17,235, Total $45,235. |
| 2010-04-29 | Edward Hurwitz was appointed to the Board on April 3, 2009. Upon his appointment, he was automatically granted a stock option to purchase 30,000 shares, with an aggregate grant date fair value of $3,765. Mr. Hurwitz waived his cash compensation in 2009. Mr. Hurwitz's total compensation for 2009 was $6,149. |
| 2011-04-21 | Edward Hurwitz has served as a director of Alta Partners, a venture capital firm, since June 2002. ... The Audit Committee is chaired by Mr. Fust, and also includes Mr. Hurwitz and Dr. Stump. ... Our Compensation Committee is chaired by Mr. Misfeldt, and also includes Messrs. Hurwitz and Fust. ... The following table sets forth the compensation information for our non-employee directors, as well as Dr. Young, the current Chairman of our Board and former Executive Chairman, for the year ended December 31, 2010. ... Edward Hurwitz Fees Earned or Paid in Cash $0, Option Awards $5,393, Total $5,393. |
| 2012-04-23 | Edward Hurwitz has served as a director of Alta Partners, a venture capital firm, since June 2002. Mr. Hurwitz also serves on the boards of directors of Cara Therapeutics, Inc. and MacroGenics, Inc. Mr. Hurwitz was appointed as a director pursuant to the Investor Rights Agreement executed in connection with Alta Partners' purchase of our securities in a private placement of equity securities in April 2009. The Board has concluded that Mr. Hurwitz should serve on our Board due to his financial, legal and scientific expertise. On March 22, 2012, Mr. Hurwitz resigned as a member of the Audit Committee and Compensation Committee. Mr. Hurwitz waived his cash compensation in 2011. Director Compensation Table shows total compensation of $72,690. |
| 2013-04-25 | Edward Hurwitz has served as a director of Alta Partners, a venture capital firm, since June 2002. ... Mr. Hurwitz served on the Audit Committee until his resignation from the Audit Committee on March 22, 2012. ... Mr. Hurwitz served on the Compensation Committee until his resignation from the Compensation Committee on March 22, 2012. ... The following table sets forth the compensation information for our non-employee directors for the year ended December 31, 2012. ... Edward Hurwitz total compensation $50,480. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22